Desperate patients get early access to promising new drug
NCT ID NCT07629401
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This program allows individual patients with serious or life-threatening conditions to request early access to retatrutide before it is fully approved. The drug is intended to help control the disease, but ongoing management may still be needed. Eligibility is determined on a case-by-case basis by the sponsor.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?